{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:29:46Z","timestamp":1794274186437,"version":"4.9.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,9,3]],"date-time":"2007-09-03T00:00:00Z","timestamp":1188777600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s00417-007-0663-9","type":"journal-article","created":{"date-parts":[[2007,9,2]],"date-time":"2007-09-02T15:43:31Z","timestamp":1188747811000},"page":"363-368","source":"Crossref","is-referenced-by-count":13,"title":["The effect of thalidomide on vascular endothelial growth factor and tumor necrosis factor-\u03b1 levels in retinal ischemia\/reperfusion injury"],"prefix":"10.1007","volume":"246","author":[{"given":"Semih","family":"Aydo\u011fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00dclk\u00fc","family":"\u00c7eliker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peykan","family":"T\u00fcrk\u00e7\u00fco\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevin","family":"\u0130lhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nusret","family":"Akpolat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,9,3]]},"reference":[{"key":"663_CR1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000267910","volume":"28","author":"M Hangai","year":"1996","unstructured":"Hangai M, Yoshimura N, Honda Y (1996) Increased cytokine gene expression in rat retina following transient ischemia. Ophthalmic Res 28:248\u2013254","journal-title":"Ophthalmic Res"},{"key":"663_CR2","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1076\/ceyr.17.11.1087.5234","volume":"17","author":"N Ogata","year":"1998","unstructured":"Ogata N, Yamanaka R, Yamamoto C, Miyashiro M, Kimoto T, Takahashi K, Maruyama K, Uyama M (1998) Expression of vascular endothelial growth factor and its receptor, KDR, following retinal ischemia-reperfusion injury in the rat. Curr Eye Res 17:1087\u20131096","journal-title":"Curr Eye Res"},{"key":"663_CR3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0014-4827(87)90191-1","volume":"169","author":"CH Chen","year":"1987","unstructured":"Chen CH, Chen SC (1987) Evidence of the presence of a specific vascular endothelial growth factor in fetal bovine retina. Exp Cell Res 169:287\u2013295","journal-title":"Exp Cell Res"},{"key":"663_CR4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/BF03401566","volume":"1","author":"DT Shima","year":"1995","unstructured":"Shima DT, Adamis AP, Ferrara N, Yeo KT, Yeo TK, Allende R, Folkman J, D\u2019Amore PA (1995) Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med 1:182\u2013193","journal-title":"Mol Med"},{"key":"663_CR5","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archopht.119.6.861","volume":"119","author":"P Hofman","year":"2001","unstructured":"Hofman P, van Blijswijk BC, Gaillard PJ, Vrensen GF, Schlingemann RO (2001) Endothelial cell hypertrophy induced by vascular endothelial growth factor in the retina: new insights into the pathogenesis of capillary nonperfusion. Arch Ophthalmol 119:861\u2013866","journal-title":"Arch Ophthalmol"},{"key":"663_CR6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00006982-200603000-00016","volume":"26","author":"RL Avery","year":"2006","unstructured":"Avery RL (2006) Regression of retinal and iris neovascularization after Intravitreal bevacizumab (Avastin) treatment. Retina 26:352\u2013354","journal-title":"Retina"},{"key":"663_CR7","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1073\/pnas.84.15.5277","volume":"84","author":"M Frater-Schroder","year":"1987","unstructured":"Frater-Schroder M, Risau W, Hallmann R, Gautschi P, Bohlen P (1987) Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 84:5277\u20135281","journal-title":"Proc Natl Acad Sci USA"},{"key":"663_CR8","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/329630a0","volume":"329","author":"SJ Leibovich","year":"1987","unstructured":"Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N (1987) Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 329:630\u2013632","journal-title":"Nature"},{"key":"663_CR9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","volume":"18","author":"N Ferrara","year":"1997","unstructured":"Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4\u201325","journal-title":"Endocr Rev"},{"key":"663_CR10","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1016\/S0021-9258(19)49853-0","volume":"267","author":"J Folkman","year":"1992","unstructured":"Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267:10931\u201310934","journal-title":"J Biol Chem"},{"key":"663_CR11","first-page":"260","volume":"43","author":"S Majka","year":"2002","unstructured":"Majka S, McGuire PG, Das A (2002) Regulation of matrix metalloproteinase expression by tumor necrosis factor in a murine model of retinal neovascularization. Invest Ophthalmol Vis Sci 43:260\u2013266","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"663_CR12","first-page":"2462","volume":"43","author":"NL Derevjanik","year":"2002","unstructured":"Derevjanik NL, Vinores SA, Xiao WH, Mori K, Turon T, Hudish T, Dong S, Campochiaro PA (2002) Quantitative assessment of the integrity of the blood-retinal barrier in mice. Invest Ophthalmol Vis Sci 43:2462\u20132467","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"663_CR13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/cpt196563303","volume":"6","author":"J Sheskin","year":"1965","unstructured":"Sheskin J (1965) Thalidomide in the treatment of lepra reactions. Clin Pharmacol Ther 6:303\u2013306","journal-title":"Clin Pharmacol Ther"},{"key":"663_CR14","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","volume":"91","author":"RJ D\u2019Amato","year":"1994","unstructured":"D\u2019Amato RJ, Loughnan MS, Flynn E, Folkman J (1994) Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91:4082\u20134085","journal-title":"Proc Natl Acad Sci USA"},{"key":"663_CR15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0304-3959(00)00333-X","volume":"88","author":"A George","year":"2000","unstructured":"George A, Marziniak M, Schafers M, Toyka KV, Sommer C (2000) Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-alpha, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin. Pain 88:267\u2013275","journal-title":"Pain"},{"key":"663_CR16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0014-4835(91)90215-Z","volume":"53","author":"WF Hughes","year":"1991","unstructured":"Hughes WF (1991) Quantitation of ischemic damage in the rat retina. Exp Eye Res 53:573\u2013582","journal-title":"Exp Eye Res"},{"key":"663_CR17","first-page":"1471","volume":"32","author":"ME Szabo","year":"1991","unstructured":"Szabo ME, Droy-Lefaix MT, Doly M, Carre C, Braquet P (1991) Ischemia and reperfusion-induced histologic changes in the rat retina. Demonstration of a free radical mediated mechanism. Invest Ophthalmol Vis Sci 32:1471\u20131478","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"663_CR18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/BF03401566","volume":"1","author":"DT Shima","year":"1995","unstructured":"Shima DT, Adamis AP, Ferrara N, Yeo KT, Yeo TK, Allende R, Folkman J, D\u2019Amore PA (1995) Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med 1:182\u2013193","journal-title":"Mol Med"},{"key":"663_CR19","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1001\/archopht.1995.01100120068012","volume":"113","author":"LP Aiello","year":"1995","unstructured":"Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA (1995) Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 113:1538\u20131544","journal-title":"Arch Ophthalmol"},{"key":"663_CR20","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1006\/exer.1997.0292","volume":"64","author":"BM Kenyon","year":"1997","unstructured":"Kenyon BM, Browne F, D\u2019Amato RJ (1997) Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization. Exp Eye Res 64:971\u2013978","journal-title":"Exp Eye Res"},{"key":"663_CR21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1182\/blood-2004-09-3679","volume":"106","author":"T Yabu","year":"2005","unstructured":"Yabu T, Tomimoto H, Taguchi Y, Yamaoka S, Igarashi Y, Okazaki T (2005) Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate. Blood 106:125\u2013134","journal-title":"Blood"},{"key":"663_CR22","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1016\/j.lfs.2005.10.016","volume":"78","author":"J Komorowski","year":"2006","unstructured":"Komorowski J, Jerczynska H, Siejka A, Baranska P, Lawnicka H, Pawlowska Z, Stepien H (2006) Effect of thalidomide affecting VEGF secretion, cell migration, adhesion and capillary tube formation of human endothelial EA.hy 926 cells. Life Sci 78:2558\u20132563","journal-title":"Life Sci"},{"key":"663_CR23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1098-1136(200010)32:1<42::AID-GLIA40>3.0.CO;2-3","volume":"32","author":"L Yuan","year":"2000","unstructured":"Yuan L, Neufeld AH (2000) Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 32:42\u201350","journal-title":"Glia"},{"key":"663_CR24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0014-5793(95)01147-7","volume":"374","author":"O Geyer","year":"1995","unstructured":"Geyer O, Almog J, Lupu-Meiri M, Lazar M, Oron Y (1995) Nitric oxide synthase inhibitors protect rat retina against ischemic injury. FEBS Lett 374:399\u2013402","journal-title":"FEBS Lett"},{"key":"663_CR25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1006\/exer.1996.0140","volume":"63","author":"M Hangai","year":"1996","unstructured":"Hangai M, Yoshimura N, Hiroi K, Mandai M, Honda Y (1996) Inducible nitric oxide synthase in retinal ischemia-reperfusion injury. Exp Eye Res 63:501\u2013509","journal-title":"Exp Eye Res"},{"key":"663_CR26","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0002-9440(10)62495-9","volume":"166","author":"JS Lee","year":"2005","unstructured":"Lee JS, Kang Decker N, Chatterjee S, Yao J, Friedman S, Shah V (2005) Mechanisms of nitric oxide interplay with Rho GTPase family members in modulation of actin membrane dynamics in pericytes and fibroblasts. Am J Pathol 166:1861\u20131870","journal-title":"Am J Pathol"},{"key":"663_CR27","first-page":"1616","volume":"23","author":"JC Lopez-Talavera","year":"1996","unstructured":"Lopez-Talavera JC, Cadelina G, Olchowski J, Merrill W, Groszmann RJ (1996) Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats. Hepatology 23:1616\u20131621","journal-title":"Hepatology"},{"key":"663_CR28","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.177.6.1675","volume":"177","author":"AL Moreira","year":"1993","unstructured":"Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G (1993) Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med 177:1675\u20131680","journal-title":"J Exp Med"},{"key":"663_CR29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/10408369009105897","volume":"28","author":"JS Warren","year":"1990","unstructured":"Warren JS (1990) Interleukins and tumor necrosis factor in inflammation. Crit Rev Clin Lab Sci 28:37\u201359","journal-title":"Crit Rev Clin Lab Sci"},{"key":"663_CR30","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/PL00005087","volume":"356","author":"S Dunzendorfer","year":"1997","unstructured":"Dunzendorfer S, Schratzberger P, Reinisch N, Kahler CM, Wiedermann CJ (1997) Effects of thalidomide on neutrophil respiratory burst, chemotaxis, and transmigration of cytokine-and endotoxin-activated endothelium. Naunyn Schmiedebergs Arch Pharmacol 356:529\u2013535","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"663_CR31","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.4049\/jimmunol.168.6.2644","volume":"168","author":"S Majumdar","year":"2002","unstructured":"Majumdar S, Lamothe B, Aggarwal BB (2002) Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester. J Immunol 168:2644\u20132651","journal-title":"J Immunol"},{"key":"663_CR32","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1381612053382179","volume":"11","author":"K Yasui","year":"2005","unstructured":"Yasui K, Kobayashi N, Yamazaki T, Agematsu K (2005) Thalidomide as an immunotherapeutic agent: the effects on neutrophil-mediated inflammation. Curr Pharm Des 11:395\u2013401","journal-title":"Curr Pharm Des"},{"key":"663_CR33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00307645","volume":"89","author":"JM Schroder","year":"1995","unstructured":"Schroder JM, Sellhaus B, Wohrmann T, Kogel B, Zwingenberger K (1995) Inhibitory effects of thalidomide on cellular proliferation, endoneurial edema and myelin phagocytosis during early wallerian degeneration. Acta Neuropathol (Berl) 89:415\u2013419","journal-title":"Acta Neuropathol (Berl)"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-007-0663-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-007-0663-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-007-0663-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T18:06:21Z","timestamp":1629655581000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-007-0663-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["663"],"URL":"https:\/\/doi.org\/10.1007\/s00417-007-0663-9","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,3]]}}}